DOCSLIB.ORG

Table S8. Positively Selected Genes (Psgs) Identified in Glyptosternoid and Yellowhead Catfish Lineages

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Table S8. Positively Selected Genes (Psgs) Identified in Glyptosternoid and Yellowhead Catfish Lineages Table S8. positively selected genes (PSGs) identified in glyptosternoid and yellowhead catfish lineages. Lineage Gene ID Gene name Gene description P-value Corrected P-value G. maculatum ENSDARG00000000001 slc35a5 solute carrier family 35, member A5 0 0 G. maculatum ENSDARG00000000656 psmb9a proteasome (prosome, macropain) subunit, beta type, 9a 0 0 aldo-keto reductase family 7, member A3 (aflatoxin aldehyde G. maculatum ENSDARG00000016649 akr7a3 0 0 reductase) G. maculatum ENSDARG00000017422 apmap adipocyte plasma membrane associated protein 0 0 G. maculatum ENSDARG00000003813 srp54 signal recognition particle 54 0 0 G. maculatum ENSDARG00000016173 cct3 chaperonin containing TCP1, subunit 3 (gamma) 0.012102523 0.049848505 G. maculatum ENSDARG00000018049 sf3b2 splicing factor 3b, subunit 2 0 0 G. maculatum ENSDARG00000004581 sel1l sel-1 suppressor of lin-12-like (C. elegans) 0.004079946 0.01759805 G. maculatum ENSDARG00000020344 slc2a8 solute carrier family 2 (facilitated glucose transporter), member 8 0.00E+00 0 G. maculatum ENSDARG00000011885 mrpl19 mitochondrial ribosomal protein L19 0 0 G. maculatum ENSDARG00000012640 cideb cell death-inducing DFFA-like effector b 0.00112672 0.005077819 G. maculatum ENSDARG00000003127 zgc:123105 zgc:123105 0 0 G. maculatum ENSDARG00000012929 eif2d eukaryotic translation initiation factor 2D 0.001049906 0.004752953 G. maculatum ENSDARG00000012947 SKA2 spindle and kinetochore associated complex subunit 2 0 0 G. maculatum ENSDARG00000015851 pnn pinin, desmosome associated protein 0 0 G. maculatum ENSDARG00000011418 sigmar1 sigma non-opioid intracellular receptor 1 0.00E+00 0 G. maculatum ENSDARG00000006926 btd biotinidase 0 0 G. maculatum ENSDARG00000012674 rpusd4 RNA pseudouridylate synthase domain containing 4 0.00E+00 0 G. maculatum ENSDARG00000017389 igfbp7 insulin-like growth factor binding protein 7 1.05E-02 0.043622349 G. maculatum ENSDARG00000013478 rrp15 ribosomal RNA processing 15 homolog (S. cerevisiae) 0 0 Lineage Gene ID Gene name Gene description P-value Corrected P-value G. maculatum ENSDARG00000015221 nsrp1 nuclear speckle splicing regulatory protein 1 0.00E+00 0 G. maculatum ENSDARG00000021439 ncoa4 nuclear receptor coactivator 4 0 0 G. maculatum ENSDARG00000001897 man2b1 mannosidase, alpha, class 2B, member 1 0 0 G. maculatum ENSDARG00000019772 C2 complement component 2 0 0 G. maculatum ENSDARG00000010312 cp ceruloplasmin 0 0 G. maculatum ENSDARG00000010108 bri3bp bri3 binding protein 0 0 G. maculatum ENSDARG00000006005 nudcd3 NudC domain containing 3 0.00E+00 0 G. maculatum ENSDARG00000008395 snupn snurportin 1 0 0 G. maculatum ENSDARG00000021120 ndc1 NDC1 transmembrane nucleoporin 0.008300323 0.035049683 G. maculatum ENSDARG00000013016 POLE4 polymerase (DNA-directed), epsilon 4, accessory subunit 0 0 G. maculatum ENSDARG00000019732 mtch2 mitochondrial carrier homolog 2 0.00E+00 0 G. maculatum ENSDARG00000013542 lpgat1 lysophosphatidylglycerol acyltransferase 1 0 0 G. maculatum ENSDARG00000020895 bag1 BCL2-associated athanogene 1 0 0 G. maculatum ENSDARG00000004665 hspa5 heat shock protein 5 0 0 G. maculatum ENSDARG00000012777 nucks1b nuclear casein kinase and cyclin-dependent kinase substrate 1b 0 0 G. maculatum ENSDARG00000003940 mtfr1l mitochondrial fission regulator 1-like 0 0 G. maculatum ENSDARG00000017046 wbp11 WW domain binding protein 11 0.000825745 0.003824303 G. maculatum ENSDARG00000018953 gclm glutamate-cysteine ligase, modifier subunit 0 0 UDP-N-acetyl-alpha-D-galactosamine:polypeptide G. maculatum ENSDARG00000003829 galnt2 0 0 N-acetylgalactosaminyltransferase 2 SWI/SNF related, matrix associated, actin dependent regulator of G. maculatum ENSDARG00000016871 smarce1 1.18E-05 5.71E-05 chromatin, subfamily e, member 1 G. maculatum ENSDARG00000004470 prkcsh protein kinase C substrate 80K-H 0.00E+00 0 G. maculatum ENSDARG00000012066 dcn decorin 0 0 Lineage Gene ID Gene name Gene description P-value Corrected P-value G. maculatum ENSDARG00000010021 grpel1 GrpE-like 1, mitochondrial 0.00E+00 0 G. maculatum ENSDARG00000011958 ctnnbl1 catenin, beta like 1 0 0 G. maculatum ENSDARG00000012256 taldo1 transaldolase 1 0.00E+00 0 G. maculatum ENSDARG00000014472 eif4a3 eukaryotic translation initiation factor 4A, isoform 3 0.00E+00 0 G. maculatum ENSDARG00000009868 dcaf11 ddb1 and cul4 associated factor 11 0 0 G. maculatum ENSDARG00000008292 eif2s3 eukaryotic translation initiation factor 2, subunit 3 gamma 0 0 G. maculatum ENSDARG00000025538 TMEM254 transmembrane protein 254 0 0 G. maculatum ENSDARG00000024818 rilpl2 Rab interacting lysosomal protein-like 2 2.50E-09 1.24E-08 G. maculatum ENSDARG00000025421 tdrd3 tudor domain containing 3 0.002871064 0.012655348 G. maculatum ENSDARG00000025269 pdcd6ip programmed cell death 6 interacting protein 0.00E+00 0 G. maculatum ENSDARG00000026149 slc46a1 solute carrier family 46, member 1 0 0 G. maculatum ENSDARG00000020323 nup153 nucleoporin 153 0.010289313 0.043086496 G. maculatum ENSDARG00000052374 faf2 Fas associated factor family member 2 0 0 G. maculatum ENSDARG00000026892 gpatch11 G patch domain containing 11 5.25E-08 2.57E-07 G. maculatum ENSDARG00000027078 cnppd1 cyclin Pas1/PHO80 domain containing 1 0.00E+00 0 G. maculatum ENSDARG00000022340 ufc1 ubiquitin-fold modifier conjugating enzyme 1 0 0 G. maculatum ENSDARG00000023309 spryd4 SPRY domain containing 4 0 0 G. maculatum ENSDARG00000022232 ppan peter pan homolog (Drosophila) 0.00091226 0.004186396 G. maculatum ENSDARG00000025635 atp5h ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d 0 0 G. maculatum ENSDARG00000032769 slc38a9 solute carrier family 38, member 9 0.00E+00 0 G. maculatum ENSDARG00000034568 fitm2 fat storage-inducing transmembrane protein 2 0 0 G. maculatum ENSDARG00000028889 ndufb10 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10 0 0 G. maculatum ENSDARG00000033586 ryroxd1 pyridine nucleotide-disulphide oxidoreductase domain 1 0 0 G. maculatum ENSDARG00000075380 kri1 KRI1 homolog 0 0 Lineage Gene ID Gene name Gene description P-value Corrected P-value G. maculatum ENSDARG00000016132 keap1a kelch-like ECH-associated protein 1a 0 0 G. maculatum ENSDARG00000002830 trmt2a trm2 tRNA methyltransferase 2 homolog A (S. cerevisiae) 0 0 G. maculatum ENSDARG00000023583 coq9 coenzyme Q9 homolog (S. cerevisiae) 0 0 G. maculatum ENSDARG00000030949 srprb signal recognition particle receptor, B subunit 0 0 G. maculatum ENSDARG00000030585 rpl13 ribosomal protein L13 0 0 G. maculatum ENSDARG00000029874 khk ketohexokinase 0 0 G. maculatum ENSDARG00000029724 pqbp1 polyglutamine binding protein 1 0 0 G. maculatum ENSDARG00000015179 mfsd8 major facilitator superfamily domain containing 8 0 0 G. maculatum ENSDARG00000036438 ndufv1 NADH dehydrogenase (ubiquinone) flavoprotein 1 0 0 G. maculatum ENSDARG00000036784 commd7 COMM domain containing 7 0 0 G. maculatum ENSDARG00000051971 arl6ip4 ADP-ribosylation-like factor 6 interacting protein 4 0.00026288 0.001240347 G. maculatum ENSDARG00000037191 ttr transthyretin (prealbumin, amyloidosis type I) 0 0 G. maculatum ENSDARG00000037423 SMIM19 small integral membrane protein 19 0 0 G. maculatum ENSDARG00000004726 trappc11 trafficking protein particle complex 11 0 0 G. maculatum ENSDARG00000037906 alkbh7 alkB, alkylation repair homolog 7 (E. coli) 0 0 G. maculatum ENSDARG00000037955 pih1d1 PIH1 domain containing 1 3.00E-09 1.48E-08 G. maculatum ENSDARG00000073858 pex26 peroxisomal biogenesis factor 26 0.005419477 0.02317691 G. maculatum ENSDARG00000063446 iba57 IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) 0 0 G. maculatum ENSDARG00000038399 polr3h polymerase (RNA) III (DNA directed) polypeptide H 0.001401418 0.006259667 G. maculatum ENSDARG00000039456 acbd6 acyl-Coenzyme A binding domain containing 6 0 0 G. maculatum ENSDARG00000042630 hebp2 heme binding protein 2 0 0 G. maculatum ENSDARG00000040555 bckdha branched chain keto acid dehydrogenase E1, alpha polypeptide 0 0 G. maculatum ENSDARG00000040620 psmg1 proteasome (prosome, macropain) assembly chaperone 1 0 0 G. maculatum ENSDARG00000040730 wdr75 WD repeat domain 75 0 0 Lineage Gene ID Gene name Gene description P-value Corrected P-value G. maculatum ENSDARG00000041088 tufm Tu translation elongation factor, mitochondrial 0.003994488 0.017303707 G. maculatum ENSDARG00000041338 mrpl15 mitochondrial ribosomal protein L15 0 0 G. maculatum ENSDARG00000041362 chmp7 CHMP family, member 7 0 0 G. maculatum ENSDARG00000041575 trmt10c tRNA methyltransferase 10 homolog C (S. cerevisiae) 0 0 G. maculatum ENSDARG00000041830 tsn translin 0 0 G. maculatum ENSDARG00000042458 rfc4 replication factor C (activator 1) 4 0 0 G. maculatum ENSDARG00000042780 apoba apolipoprotein Ba 0 0 G. maculatum ENSDARG00000042821 agps alkylglycerone phosphate synthase 0 0 G. maculatum ENSDARG00000043105 qtrt1 queuine tRNA-ribosyltransferase 1 0 0 G. maculatum ENSDARG00000043457 gapdh glyceraldehyde-3-phosphate dehydrogenase 0.004176678 0.017938294 G. maculatum ENSDARG00000043467 ndufb11 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11 0 0 G. maculatum ENSDARG00000043502 ccdc124 coiled-coil domain containing 124 0 0 G. maculatum ENSDARG00000017864 txnrd1 thioredoxin reductase 1 0 0 G. maculatum ENSDARG00000044097 stoml2 stomatin (EPB72)-like 2 0 0 G. maculatum ENSDARG00000044402 nop16 NOP16 nucleolar protein homolog (yeast) 0 0 G. maculatum ENSDARG00000044405 ttc4 tetratricopeptide repeat domain 4 0.000856454 0.003948332 G. maculatum ENSDARG00000044853 rrp7a ribosomal RNA processing 7 homolog A (S. cerevisiae) 0 0 G. maculatum ENSDARG00000045399 cct5 chaperonin containing
Load more

Recommended publications
  • Different Genetic Mechanisms Mediate Spontaneous Versus UVR-Induced
    RESEARCH ARTICLE Different genetic mechanisms mediate spontaneous versus UVR-induced malignant melanoma Blake Ferguson1, Herlina Y Handoko1, Pamela Mukhopadhyay1, Arash Chitsazan1, Lois Balmer2,3, Grant Morahan2, Graeme J Walker1†* 1Drug Discovery Group, QIMR Berghofer Medical Research Institute, Herston, Australia; 2Centre for Diabetes Research, Harry Perkins Institute of Medical Research, Perth, Australia; 3School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia Abstract Genetic variation conferring resistance and susceptibility to carcinogen-induced tumorigenesis is frequently studied in mice. We have now turned this idea to melanoma using the collaborative cross (CC), a resource of mouse strains designed to discover genes for complex diseases. We studied melanoma-prone transgenic progeny across seventy CC genetic backgrounds. We mapped a strong quantitative trait locus for rapid onset spontaneous melanoma onset to Prkdc, a gene involved in detection and repair of DNA damage. In contrast, rapid onset UVR-induced melanoma was linked to the ribosomal subunit gene Rrp15. Ribosome biogenesis was upregulated in skin shortly after UVR exposure. Mechanistically, variation in the ‘usual suspects’ by which UVR may exacerbate melanoma, defective DNA repair, melanocyte proliferation, or inflammatory cell infiltration, did not explain melanoma susceptibility or resistance across the CC. *For correspondence: [email protected] Instead, events occurring soon after exposure, such as dysregulation of ribosome function, which alters many aspects of cellular metabolism, may be important. † Present address: Experimental DOI: https://doi.org/10.7554/eLife.42424.001 Dermatology Group, The University of Queensland Diamantina Institute, Woolloongabba, Australia Introduction Competing interests: The Cutaneous malignant melanoma (MM) is well known to be associated with high levels of sun expo- authors declare that no sure.
    [Show full text]
  • The Peroxisomal PTS1-Import Defect of PEX1- Deficient Cells Is Independent of Pexophagy in Saccharomyces Cerevisiae
    International Journal of Molecular Sciences Communication The Peroxisomal PTS1-Import Defect of PEX1- Deficient Cells Is Independent of Pexophagy in Saccharomyces cerevisiae Thomas Mastalski, Rebecca Brinkmeier and Harald W. Platta * Biochemie Intrazellulärer Transportprozesse, Ruhr-Universität Bochum, Universitätsstr. 150, 44801 Bochum, Germany; [email protected] (T.M.); [email protected] (R.B.) * Correspondence: [email protected]; Tel.: +49-234-3224-968 Received: 10 January 2020; Accepted: 27 January 2020; Published: 29 January 2020 Abstract: The important physiologic role of peroxisomes is shown by the occurrence of peroxisomal biogenesis disorders (PBDs) in humans. This spectrum of autosomal recessive metabolic disorders is characterized by defective peroxisome assembly and impaired peroxisomal functions. PBDs are caused by mutations in the peroxisomal biogenesis factors, which are required for the correct compartmentalization of peroxisomal matrix enzymes. Recent work from patient cells that contain the Pex1(G843D) point mutant suggested that the inhibition of the lysosome, and therefore the block of pexophagy, was beneficial for peroxisomal function. The resulting working model proposed that Pex1 may not be essential for matrix protein import at all, but rather for the prevention of pexophagy. Thus, the observed matrix protein import defect would not be caused by a lack of Pex1 activity, but rather by enhanced removal of peroxisomal membranes via pexophagy. In the present study, we can show that the specific block of PEX1 deletion-induced pexophagy does not restore peroxisomal matrix protein import or the peroxisomal function in beta-oxidation in yeast. Therefore, we conclude that Pex1 is directly and essentially involved in peroxisomal matrix protein import, and that the PEX1 deletion-induced pexophagy is not responsible for the defect in peroxisomal function.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Peroxisomal Disorders and Their Mouse Models Point to Essential Roles of Peroxisomes for Retinal Integrity
    International Journal of Molecular Sciences Review Peroxisomal Disorders and Their Mouse Models Point to Essential Roles of Peroxisomes for Retinal Integrity Yannick Das, Daniëlle Swinkels and Myriam Baes * Lab of Cell Metabolism, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium; [email protected] (Y.D.); [email protected] (D.S.) * Correspondence: [email protected] Abstract: Peroxisomes are multifunctional organelles, well known for their role in cellular lipid homeostasis. Their importance is highlighted by the life-threatening diseases caused by peroxisomal dysfunction. Importantly, most patients suffering from peroxisomal biogenesis disorders, even those with a milder disease course, present with a number of ocular symptoms, including retinopathy. Patients with a selective defect in either peroxisomal α- or β-oxidation or ether lipid synthesis also suffer from vision problems. In this review, we thoroughly discuss the ophthalmological pathology in peroxisomal disorder patients and, where possible, the corresponding animal models, with a special emphasis on the retina. In addition, we attempt to link the observed retinal phenotype to the underlying biochemical alterations. It appears that the retinal pathology is highly variable and the lack of histopathological descriptions in patients hampers the translation of the findings in the mouse models. Furthermore, it becomes clear that there are still large gaps in the current knowledge on the contribution of the different metabolic disturbances to the retinopathy, but branched chain fatty acid accumulation and impaired retinal PUFA homeostasis are likely important factors. Citation: Das, Y.; Swinkels, D.; Baes, Keywords: peroxisome; Zellweger; metabolism; fatty acid; retina M. Peroxisomal Disorders and Their Mouse Models Point to Essential Roles of Peroxisomes for Retinal Integrity.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Mutations in Novel Peroxin Gene PEX26 That Cause Peroxisome
    Am. J. Hum. Genet. 73:233–246, 2003 Mutations in Novel Peroxin Gene PEX26 That Cause Peroxisome-Biogenesis Disorders of Complementation Group 8 Provide a Genotype-Phenotype Correlation Naomi Matsumoto,1,* Shigehiko Tamura,1,* Satomi Furuki,1,* Non Miyata,1 Ann Moser,2 Nobuyuki Shimozawa,3 Hugo W. Moser,2 Yasuyuki Suzuki,3 Naomi Kondo,3 and Yukio Fujiki1,4 1Department of Biology, Faculty of Sciences, Kyushu University Graduate School, Fukuoka, Japan; 2Department of Neurology and Pediatrics, Kennedy-Krieger Institute, Johns Hopkins University, Baltimore; 3Department of Pediatrics, Gifu University School of Medicine, Gifu, Japan; and 4SORST, Japan Science and Technology Corporation, Kawaguchi, Saitama, Japan The human disorders of peroxisome biogenesis (PBDs) are subdivided into 12 complementation groups (CGs). CG8 is one of the more common of these and is associated with varying phenotypes, ranging from the most severe, Zellweger syndrome (ZS), to the milder neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD). PEX26, encoding the 305-amino-acid membrane peroxin, has been shown to be deficient in CG8. We studied the PEX26 genotype in fibroblasts of eight CG8 patients—four with the ZS phenotype, two with NALD, and two with IRD. Catalase was mostly cytosolic in all these cell lines, but import of the proteins that contained PTS1, the SKL peroxisome targeting sequence, was normal. Expression of PEX26 reestablished peroxisomes in all eight cell lines, confirming that PEX26 defects are pathogenic in CG8 patients. When cells were cultured at 30ЊC, catalase import was restored in the cell lines from patients with the NALD and IRD phenotypes, but to a much lesser extent in those with the ZS phenotype, indicating that temperature sensitivity varied inversely with the severity of the clinical phenotype.
    [Show full text]
  • Nucleolus: a Central Hub for Nuclear Functions Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, Sergey Razin, Yegor Vassetzky
    Nucleolus: A Central Hub for Nuclear Functions Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, Sergey Razin, Yegor Vassetzky To cite this version: Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, et al.. Nucleolus: A Central Hub for Nuclear Functions. Trends in Cell Biology, Elsevier, 2019, 29 (8), pp.647-659. 10.1016/j.tcb.2019.04.003. hal-02322927 HAL Id: hal-02322927 https://hal.archives-ouvertes.fr/hal-02322927 Submitted on 18 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Nucleolus: A Central Hub for Nuclear Functions Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, Sergey Razin, Yegor Vassetzky To cite this version: Olga Iarovaia, Elizaveta Minina, Eugene Sheval, Daria Onichtchouk, Svetlana Dokudovskaya, et al.. Nucleolus: A Central Hub for Nuclear Functions. Trends in Cell Biology, Elsevier, 2019, 29 (8), pp.647-659. 10.1016/j.tcb.2019.04.003. hal-02322927 HAL Id: hal-02322927 https://hal.archives-ouvertes.fr/hal-02322927 Submitted on 18 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not.
    [Show full text]
  • Recovery of PEX1-Gly843asp Associated Peroxisome Dysfunction by Flavonoid Compounds in Fibroblasts from Zellweger Spectrum Patients
    Recovery of PEX1-Gly843Asp associated peroxisome dysfunction by flavonoid compounds in fibroblasts from Zellweger spectrum patients Gillian Elizabeth MacLean Department of Human Genetics McGill University Montreal, Quebec, Canada Submitted September 2012 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Science © Gillian Elizabeth MacLean 2012 TABLE OF CONTENTS TABLE OF CONTENTS .................................................................................................2 ABSTRACT ....................................................................................................................4 RESUME ........................................................................................................................6 ABBREVIATIONS .........................................................................................................8 ACKNOWLEDGEMENTS .............................................................................................9 CHAPTER 1 .................................................................................................................. 11 Introduction ................................................................................................................... 11 Structure and function of PEX1 protein ...................................................................... 13 Recovery of PEX1-G843D by chaperone therapy ....................................................... 14 Objectives of the project............................................................................................
    [Show full text]
  • Perkinelmer Genomics to Request the Saliva Swab Collection Kit for Patients That Cannot Provide a Blood Sample As Whole Blood Is the Preferred Sample
    Zellweger Spectrum Disorder Panel Test Code D4611 Test Summary This panel analyzes 15 genes that have been associated with Zellweger Spectrum Disorders. Turn-Around-Time (TAT)* 3 - 5 weeks Acceptable Sample Types Whole Blood (EDTA) (Preferred sample type) DNA, Isolated Dried Blood Spots Saliva Acceptable Billing Types Self (patient) Payment Institutional Billing Commercial Insurance Indications for Testing This panel may be appropriate for individuals with signs and symptoms of a peroxisomal biogenesis disfuction and/or Zellweger syndrome spectrum disorder and/or a family history of these conditions. Test Description This panel analyzes 15 genes that have been associated with Zellweger Spectrum Disorders. Both sequencing and deletion/duplication (CNV) analysis will be performed on the coding regions of all genes included (unless otherwise marked). All analysis is performed utilizing Next Generation Sequencing (NGS) technology. CNV analysis is designed to detect the majority of deletions and duplications of three exons or greater in size. Smaller CNV events may also be detected and reported, but additional follow-up testing is recommended if a smaller CNV is suspected. All variants are classified according to ACMG guidelines. Condition Description Zellweger syndrome spectrum disorders include Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), an intermediate form and infantile Refsum disease (IRD). Symptoms may include hypotonia, feeding problems, hearing and vision loss, seizures, distinctive facial characteristics and skeletal abnormalities. Zellweger spectrum disorder is estimated to occur in 1/50,000 individuals. Genes ACOX1, AMACR, HSD17B4, PEX1, PEX10, PEX12, PEX13, PEX14, PEX16, PEX19, PEX2, PEX26, PEX3, PEX5, PEX6 Test Methods and Limitations Sequencing is performed on genomic DNA using an Agilent targeted sequence capture method to enrich for the genes on this panel.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • Molecular Signatures Differentiate Immune States in Type 1 Diabetes Families
    Page 1 of 65 Diabetes Molecular signatures differentiate immune states in Type 1 diabetes families Yi-Guang Chen1, Susanne M. Cabrera1, Shuang Jia1, Mary L. Kaldunski1, Joanna Kramer1, Sami Cheong2, Rhonda Geoffrey1, Mark F. Roethle1, Jeffrey E. Woodliff3, Carla J. Greenbaum4, Xujing Wang5, and Martin J. Hessner1 1The Max McGee National Research Center for Juvenile Diabetes, Children's Research Institute of Children's Hospital of Wisconsin, and Department of Pediatrics at the Medical College of Wisconsin Milwaukee, WI 53226, USA. 2The Department of Mathematical Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, USA. 3Flow Cytometry & Cell Separation Facility, Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907, USA. 4Diabetes Research Program, Benaroya Research Institute, Seattle, WA, 98101, USA. 5Systems Biology Center, the National Heart, Lung, and Blood Institute, the National Institutes of Health, Bethesda, MD 20824, USA. Corresponding author: Martin J. Hessner, Ph.D., The Department of Pediatrics, The Medical College of Wisconsin, Milwaukee, WI 53226, USA Tel: 011-1-414-955-4496; Fax: 011-1-414-955-6663; E-mail: [email protected]. Running title: Innate Inflammation in T1D Families Word count: 3999 Number of Tables: 1 Number of Figures: 7 1 For Peer Review Only Diabetes Publish Ahead of Print, published online April 23, 2014 Diabetes Page 2 of 65 ABSTRACT Mechanisms associated with Type 1 diabetes (T1D) development remain incompletely defined. Employing a sensitive array-based bioassay where patient plasma is used to induce transcriptional responses in healthy leukocytes, we previously reported disease-specific, partially IL-1 dependent, signatures associated with pre and recent onset (RO) T1D relative to unrelated healthy controls (uHC).
    [Show full text]
  • Supplementary Information Supplementary Note
    Supplementary Information Supplementary Note Bulk RNA Sequencing and Data Processing: Total RNAs from the dorsolateral prefrontal cortex (Brodmann area 8/9) of 208 brains from the FHS/BUADC study were extracted using the Promega Maxwell RSC simplyRNA Tissue Kit (Cat No# AS1340) according to the manufacturer’s protocol. The integrity and quality of RNA (RNA integrity number, RIN) was determined using the Agilent 2100 Bioanalyzer with RNA 600 Nano Chips (Cat No# 5067-1511). After excluding brain samples with RIN < 5, brain samples were randomized into seven library batches based on diagnosis, APOE genotype, sex, and RIN. Since there were only seven samples from AD cases with APOE genotypes 2/2 or 2/3, these specimens were included in batches 1 to 3 only. The BU Microarray & Sequencing Resource Core performed RNA sequencing (RNA-seq) library preparation. The libraries were prepared from total RNA enriched for mRNA using NEBNext Poly(A) mRNA Magnetic Isolation Module and NEBNext Ultra II Directional RNA Library Preparation Kit for Illumina (New England Biolabs, USA) and sequenced on an Illumina NextSeq 500 instrument (Illumina, USA). A total of 193 of the 208 samples remained for mapping after pre-processing. The average coverage of the remaining samples was 50 million reads for the entire sample. RNA-seq data from 193 FHS/BUADC brains were processed by our automated pipeline. We conducted quality control of the RNA-seq data for sequencing quality, over-abundance of adaptors, and over-represented sequence using the FastQC. Low-quality reads (5% of the total) were filtered out using the Trimmomatic option, which is a fast, multithreaded command line tool to trim and crop Illumina (FASTQ) data and remove adapters 1.
    [Show full text]